Compare $CELZ vs $LIMN | Chartloom

Compare

$CELZ vs $LIMN

Creative Medical Technology Holdings Inc · Liminatus Pharma Inc

CELZ

Creative Medical Technology Holdings Inc

LIMN

Liminatus Pharma Inc

Compare $CELZ vs $LIMN

Comparing Creative Medical Technology Holdings Inc and Liminatus Pharma Inc

CELZCreative Medical Technology Holdings Inc

LIMNLiminatus Pharma Inc

CELZCreative Medical Technology Holdings Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-50.0%

YTD performance

-57.4%

52W performance

-76.5%

FCF yield

-148.5%

LIMNLiminatus Pharma Inc

Market cap

$253M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-88.3%

52W performance

-95.3%

FCF yield

-1.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELZ

LIMN

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

LIMN

Liminatus Pharma Inc

Market Cap

CELZ$4M

LIMN$253M

Enterprise Value

CELZ$-5M

LIMN$251M

Price

CELZ$0.84

LIMN$3.76

P/E Ratio

CELZN/A

LIMNN/A

P/S Ratio

CELZ1,324.83x

LIMN0.00x

EV/Sales

CELZ-1,579.87x

LIMN0.00x

EV/EBITDA

CELZ0.00x

LIMN0.00x

P/B Ratio

CELZ0.72x

LIMN17.43x

P/FCF Ratio

CELZN/A

LIMNN/A

EV/FCF

CELZ0.80x

LIMN-62.96x

PEG Ratio

CELZN/A

LIMNN/A

Forward P/E (NTM)

CELZN/A

LIMNN/A

Forward P/S (NTM)

CELZN/A

LIMNN/A

Revenue (TTM)

CELZ$3K

LIMN$0

Revenue Growth (YoY)

CELZ-50.0%

LIMNN/A

Forward Rev Growth

CELZ56.2%

LIMN0.0%

Gross Margin (TTM)

CELZ66.7%

LIMN0.0%

Operating Margin (TTM)

CELZ0.0%

LIMN0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

LIMN0.0%

Net Margin (TTM)

CELZ-201356.7%

LIMN0.0%

FCF Margin (TTM)

CELZ-196726.7%

LIMNN/A

Net Income (TTM)

CELZ$-6M

LIMN$-13M

FCF (TTM)

CELZ$-6M

LIMN$-4M

EPS (TTM)

CELZ-$1.63

LIMN-$12.94

ROE (TTM)

CELZ-8670.0%

LIMN0.0%

ROA (TTM)

CELZ-8196.0%

LIMN-62234.0%

ROIC (TTM)

CELZ-8670.0%

LIMN0.0%

Cash

CELZ$9M

LIMN$3M

Debt

CELZ$0

LIMN$1M

Net Cash/Debt

CELZ$9M

LIMN$2M

Current Ratio (TTM)

CELZ12.91x

LIMN1.12x

Quick Ratio (TTM)

CELZ12.63x

LIMN0.99x

Debt/Equity (TTM)

CELZ0.00x

LIMN4.80x

Debt/Assets (TTM)

CELZ0.0%

LIMN0.0%

Interest Coverage (TTM)

CELZN/A

LIMNN/A

Net Debt/EBITDA (TTM)

CELZ0.00x

LIMN0.00x

Beta

CELZ1.93

LIMN0.75

52W Performance

CELZ-76.5%

LIMN-95.3%

YTD Performance

CELZ-57.4%

LIMN-88.3%

% from 52W High

CELZ-86.6%

LIMN-97.3%

% from 52W Low

CELZ35.2%

LIMN14.3%

Asset Turnover (TTM)

CELZ0.00x

LIMN0.00x

FCF Yield (TTM)

CELZ-148.5%

LIMN-1.6%

Earnings Yield (TTM)

CELZ-152.0%

LIMN-5.0%

Dividend Yield (TTM)

CELZN/A

LIMNN/A

Rule of 40

CELZ-196,776.7

LIMN0.0

EV/GP/RG

CELZN/A

LIMNN/A

Ticker research

View CELZ research View LIMN research

Metric	CELZ Creative Medical Technology Holdings Inc	LIMN Liminatus Pharma Inc
Market & Valuation
Market Cap	$4M	$253M
Enterprise Value	$-5M	$251M
Price	$0.84	$3.76
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	0.00x
EV/Sales	-1,579.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	17.43x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	-62.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$0
Revenue Growth (YoY)	-50.0%	N/A
Forward Rev Growth	56.2%	0.0%
Profitability
Gross Margin (TTM)	66.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	0.0%
Net Margin (TTM)	-201356.7%	0.0%
FCF Margin (TTM)	-196726.7%	N/A
Net Income (TTM)	$-6M	$-13M
FCF (TTM)	$-6M	$-4M
EPS (TTM)	-$1.63	-$12.94
ROE (TTM)	-8670.0%	0.0%
ROA (TTM)	-8196.0%	-62234.0%
ROIC (TTM)	-8670.0%	0.0%
Financial Health
Cash	$9M	$3M
Debt	$0	$1M
Net Cash/Debt	$9M	$2M
Current Ratio (TTM)	12.91x	1.12x
Quick Ratio (TTM)	12.63x	0.99x
Debt/Equity (TTM)	0.00x	4.80x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	0.75
52W Performance	-76.5%	-95.3%
YTD Performance	-57.4%	-88.3%
% from 52W High	-86.6%	-97.3%
% from 52W Low	35.2%	14.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-148.5%	-1.6%
Earnings Yield (TTM)	-152.0%	-5.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View LIMN research

Valuation

P/S Ratio

LIMN

0.00x

CELZ

1,324.83x

EV/FCF

LIMN

-62.96x

CELZ

0.80x

Growth & revenue

Revenue Growth TTM

CELZ

-50.0%

Forward Revenue Growth

CELZ

56.2%

LIMN

0.0%

Profitability & performance

Gross Margin

CELZ

66.7%

LIMN

0.0%

ROE

LIMN

0.0%

CELZ

-8670.0%

FCF Yield %

LIMN

-1.6%

CELZ

-148.5%

52-Week Performance

CELZ

-76.5%

LIMN

-95.3%

Detailed metrics comparison

CELZ

Creative Medical Technology Holdings Inc

LIMN

Liminatus Pharma Inc

Market Cap

CELZ$4M

LIMN$253M

Enterprise Value

CELZ$-5M

LIMN$251M

Price

CELZ$0.84

LIMN$3.76

P/E Ratio

CELZN/A

LIMNN/A

P/S Ratio

CELZ1,324.83x

LIMN0.00x

EV/Sales

CELZ-1,579.87x

LIMN0.00x

EV/EBITDA

CELZ0.00x

LIMN0.00x

P/B Ratio

CELZ0.72x

LIMN17.43x

P/FCF Ratio

CELZN/A

LIMNN/A

EV/FCF

CELZ0.80x

LIMN-62.96x

PEG Ratio

CELZN/A

LIMNN/A

Forward P/E (NTM)

CELZN/A

LIMNN/A

Forward P/S (NTM)

CELZN/A

LIMNN/A

Revenue (TTM)

CELZ$3K

LIMN$0

Revenue Growth (YoY)

CELZ-50.0%

LIMNN/A

Forward Rev Growth

CELZ56.2%

LIMN0.0%

Gross Margin (TTM)

CELZ66.7%

LIMN0.0%

Operating Margin (TTM)

CELZ0.0%

LIMN0.0%

EBITDA Margin (TTM)

CELZ-204213.3%

LIMN0.0%

Net Margin (TTM)

CELZ-201356.7%

LIMN0.0%

FCF Margin (TTM)

CELZ-196726.7%

LIMNN/A

Net Income (TTM)

CELZ$-6M

LIMN$-13M

FCF (TTM)

CELZ$-6M

LIMN$-4M

EPS (TTM)

CELZ-$1.63

LIMN-$12.94

ROE (TTM)

CELZ-8670.0%

LIMN0.0%

ROA (TTM)

CELZ-8196.0%

LIMN-62234.0%

ROIC (TTM)

CELZ-8670.0%

LIMN0.0%

Cash

CELZ$9M

LIMN$3M

Debt

CELZ$0

LIMN$1M

Net Cash/Debt

CELZ$9M

LIMN$2M

Current Ratio (TTM)

CELZ12.91x

LIMN1.12x

Quick Ratio (TTM)

CELZ12.63x

LIMN0.99x

Debt/Equity (TTM)

CELZ0.00x

LIMN4.80x

Debt/Assets (TTM)

CELZ0.0%

LIMN0.0%

Interest Coverage (TTM)

CELZN/A

LIMNN/A

Net Debt/EBITDA (TTM)

CELZ0.00x

LIMN0.00x

Beta

CELZ1.93

LIMN0.75

52W Performance

CELZ-76.5%

LIMN-95.3%

YTD Performance

CELZ-57.4%

LIMN-88.3%

% from 52W High

CELZ-86.6%

LIMN-97.3%

% from 52W Low

CELZ35.2%

LIMN14.3%

Asset Turnover (TTM)

CELZ0.00x

LIMN0.00x

FCF Yield (TTM)

CELZ-148.5%

LIMN-1.6%

Earnings Yield (TTM)

CELZ-152.0%

LIMN-5.0%

Dividend Yield (TTM)

CELZN/A

LIMNN/A

Rule of 40

CELZ-196,776.7

LIMN0.0

EV/GP/RG

CELZN/A

LIMNN/A

Ticker research

View CELZ research View LIMN research

Metric	CELZ Creative Medical Technology Holdings Inc	LIMN Liminatus Pharma Inc
Market & Valuation
Market Cap	$4M	$253M
Enterprise Value	$-5M	$251M
Price	$0.84	$3.76
P/E Ratio	N/A	N/A
P/S Ratio	1,324.83x	0.00x
EV/Sales	-1,579.87x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.72x	17.43x
P/FCF Ratio	N/A	N/A
EV/FCF	0.80x	-62.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$3K	$0
Revenue Growth (YoY)	-50.0%	N/A
Forward Rev Growth	56.2%	0.0%
Profitability
Gross Margin (TTM)	66.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204213.3%	0.0%
Net Margin (TTM)	-201356.7%	0.0%
FCF Margin (TTM)	-196726.7%	N/A
Net Income (TTM)	$-6M	$-13M
FCF (TTM)	$-6M	$-4M
EPS (TTM)	-$1.63	-$12.94
ROE (TTM)	-8670.0%	0.0%
ROA (TTM)	-8196.0%	-62234.0%
ROIC (TTM)	-8670.0%	0.0%
Financial Health
Cash	$9M	$3M
Debt	$0	$1M
Net Cash/Debt	$9M	$2M
Current Ratio (TTM)	12.91x	1.12x
Quick Ratio (TTM)	12.63x	0.99x
Debt/Equity (TTM)	0.00x	4.80x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	0.75
52W Performance	-76.5%	-95.3%
YTD Performance	-57.4%	-88.3%
% from 52W High	-86.6%	-97.3%
% from 52W Low	35.2%	14.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-148.5%	-1.6%
Earnings Yield (TTM)	-152.0%	-5.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-196,776.7	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CELZ research	View LIMN research